Company Filing History:
Years Active: 2014
Title: **Innovative Vaccine Formulation by Nelson Acosta Rivero**
Introduction
Nelson Acosta Rivero is a notable inventor based in Ciudad de la Habana, Cuba, recognized for his significant contributions to the field of vaccine development. His innovative approach has led to the creation of a groundbreaking vaccine formulation that harnesses the power of DNA and viral antigens to enhance immune responses.
Latest Patents
Mr. Rivero holds a patent for a "Vaccine formulation potentiated by the combination of DNA and an antigen." This formulation consists of two main components: a DNA component that expresses one or more proteins within immunized individuals, and a viral antigen, formulated in appropriate proportions. The development of this new formulation aims to minimize the number of components while enhancing and diversifying the immune response spectrum against various pathogenic entities. Such combined vaccines hold promising potential for both preventive and therapeutic applications within the pharmaceutical industry.
Career Highlights
Nelson Acosta Rivero works at the Centro de Ingeniería Genética y Biotecnología, a prestigious institution dedicated to genetic engineering and biotechnology research. His innovative work in vaccine formulation exemplifies his commitment to advancing medical science and public health.
Collaborations
Throughout his career, Mr. Rivero has collaborated with esteemed colleagues, including Santiago Duenas Carrera and Juan Morales Grillo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their research initiatives.
Conclusion
In summary, Nelson Acosta Rivero stands out as an influential inventor in the realm of vaccine formulation. His patent exemplifies a significant advancement in biotechnology, with the potential to revolutionize vaccine development and improve health outcomes globally. Through his work at the Centro de Ingeniería Genética y Biotecnología and collaborations with fellow researchers, he continues to contribute to the field of medical science, paving the way for future innovations.